vs
Esperion Therapeutics, Inc.(ESPR)与POWER SOLUTIONS INTERNATIONAL, INC.(PSIX)财务数据对比。点击上方公司名可切换其他公司
POWER SOLUTIONS INTERNATIONAL, INC.的季度营收约是Esperion Therapeutics, Inc.的1.1倍($191.2M vs $168.4M),Esperion Therapeutics, Inc.同比增速更快(143.7% vs 32.5%),过去两年POWER SOLUTIONS INTERNATIONAL, INC.的营收复合增速更高(41.7% vs 10.6%)
Esperion Therapeutics, Inc.是一家上市美国药企,专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸,公司总部位于密歇根州安娜堡,目前核心研发管线围绕这款降脂创新药物推进,深耕血脂异常治疗领域的创新药物开发。
阿达尼能源解决方案有限公司(前身为阿达尼输电有限公司)是一家电力输配企业,总部位于艾哈迈达巴德。截至2025年4月,公司累计输电网络总长26696回路公里,是印度规模最大的民营输电企业之一。
ESPR vs PSIX — 直观对比
营收规模更大
PSIX
是对方的1.1倍
$168.4M
营收增速更快
ESPR
高出111.2%
32.5%
两年增速更快
PSIX
近两年复合增速
10.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $168.4M | $191.2M |
| 净利润 | — | $16.1M |
| 毛利率 | — | 21.9% |
| 营业利润率 | 50.6% | 12.7% |
| 净利率 | — | 8.4% |
| 营收同比 | 143.7% | 32.5% |
| 净利润同比 | — | -31.0% |
| 每股收益(稀释后) | $0.32 | $0.69 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ESPR
PSIX
| Q4 25 | $168.4M | $191.2M | ||
| Q3 25 | $87.3M | $203.8M | ||
| Q2 25 | $82.4M | $191.9M | ||
| Q1 25 | $65.0M | $135.4M | ||
| Q4 24 | $69.1M | $144.3M | ||
| Q3 24 | $51.6M | $125.8M | ||
| Q2 24 | $73.8M | $110.6M | ||
| Q1 24 | $137.7M | $95.2M |
净利润
ESPR
PSIX
| Q4 25 | — | $16.1M | ||
| Q3 25 | $-31.3M | $27.6M | ||
| Q2 25 | $-12.7M | $51.2M | ||
| Q1 25 | $-40.5M | $19.1M | ||
| Q4 24 | — | $23.3M | ||
| Q3 24 | $-29.5M | $17.3M | ||
| Q2 24 | $-61.9M | $21.5M | ||
| Q1 24 | $61.0M | $7.1M |
毛利率
ESPR
PSIX
| Q4 25 | — | 21.9% | ||
| Q3 25 | — | 23.9% | ||
| Q2 25 | — | 28.2% | ||
| Q1 25 | — | 29.7% | ||
| Q4 24 | — | 29.9% | ||
| Q3 24 | — | 28.9% | ||
| Q2 24 | — | 31.8% | ||
| Q1 24 | — | 27.0% |
营业利润率
ESPR
PSIX
| Q4 25 | 50.6% | 12.7% | ||
| Q3 25 | -11.4% | 13.9% | ||
| Q2 25 | 8.6% | 16.9% | ||
| Q1 25 | -34.0% | 18.2% | ||
| Q4 24 | -6.4% | 17.5% | ||
| Q3 24 | -31.0% | 16.3% | ||
| Q2 24 | 3.5% | 22.9% | ||
| Q1 24 | 52.5% | 11.2% |
净利率
ESPR
PSIX
| Q4 25 | — | 8.4% | ||
| Q3 25 | -35.9% | 13.5% | ||
| Q2 25 | -15.4% | 26.7% | ||
| Q1 25 | -62.2% | 14.1% | ||
| Q4 24 | — | 16.1% | ||
| Q3 24 | -57.2% | 13.8% | ||
| Q2 24 | -83.9% | 19.5% | ||
| Q1 24 | 44.3% | 7.5% |
每股收益(稀释后)
ESPR
PSIX
| Q4 25 | $0.32 | $0.69 | ||
| Q3 25 | $-0.16 | $1.20 | ||
| Q2 25 | $-0.06 | $2.22 | ||
| Q1 25 | $-0.21 | $0.83 | ||
| Q4 24 | $-0.14 | $1.01 | ||
| Q3 24 | $-0.15 | $0.75 | ||
| Q2 24 | $-0.33 | $0.94 | ||
| Q1 24 | $0.34 | $0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | $41.3M |
| 总债务越低越好 | — | $96.6M |
| 股东权益账面价值 | $-302.0M | $178.6M |
| 总资产 | $465.9M | $424.7M |
| 负债/权益比越低杠杆越低 | — | 0.54× |
8季度趋势,按日历期对齐
现金及短期投资
ESPR
PSIX
| Q4 25 | $167.9M | $41.3M | ||
| Q3 25 | $92.4M | $49.0M | ||
| Q2 25 | $86.1M | $49.5M | ||
| Q1 25 | $114.6M | $50.0M | ||
| Q4 24 | $144.8M | $55.3M | ||
| Q3 24 | $144.7M | $40.5M | ||
| Q2 24 | $189.3M | $28.8M | ||
| Q1 24 | $226.6M | $33.1M |
总债务
ESPR
PSIX
| Q4 25 | — | $96.6M | ||
| Q3 25 | — | $96.7M | ||
| Q2 25 | — | $1.8M | ||
| Q1 25 | — | $1.0M | ||
| Q4 24 | — | $184.0K | ||
| Q3 24 | — | $238.0K | ||
| Q2 24 | — | $292.0K | ||
| Q1 24 | — | $345.0K |
股东权益
ESPR
PSIX
| Q4 25 | $-302.0M | $178.6M | ||
| Q3 25 | $-451.4M | $162.5M | ||
| Q2 25 | $-433.5M | $135.7M | ||
| Q1 25 | $-426.2M | $84.3M | ||
| Q4 24 | $-388.7M | $65.3M | ||
| Q3 24 | $-370.2M | $42.1M | ||
| Q2 24 | $-344.2M | $24.8M | ||
| Q1 24 | $-294.3M | $3.2M |
总资产
ESPR
PSIX
| Q4 25 | $465.9M | $424.7M | ||
| Q3 25 | $364.0M | $458.9M | ||
| Q2 25 | $347.1M | $437.7M | ||
| Q1 25 | $324.0M | $372.7M | ||
| Q4 24 | $343.8M | $328.2M | ||
| Q3 24 | $314.1M | $339.1M | ||
| Q2 24 | $352.3M | $307.6M | ||
| Q1 24 | $373.1M | $286.8M |
负债/权益比
ESPR
PSIX
| Q4 25 | — | 0.54× | ||
| Q3 25 | — | 0.60× | ||
| Q2 25 | — | 0.01× | ||
| Q1 25 | — | 0.01× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.01× | ||
| Q2 24 | — | 0.01× | ||
| Q1 24 | — | 0.11× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $45.2M | $-4.6M |
| 自由现金流经营现金流 - 资本支出 | — | $-7.6M |
| 自由现金流率自由现金流/营收 | — | -4.0% |
| 资本支出强度资本支出/营收 | 0.0% | 1.6% |
| 现金转化率经营现金流/净利润 | — | -0.29× |
| 过去12个月自由现金流最近4个季度 | — | $14.1M |
8季度趋势,按日历期对齐
经营现金流
ESPR
PSIX
| Q4 25 | $45.2M | $-4.6M | ||
| Q3 25 | $-4.3M | $3.3M | ||
| Q2 25 | $-31.4M | $16.7M | ||
| Q1 25 | $-22.6M | $8.8M | ||
| Q4 24 | $-35.0M | $32.7M | ||
| Q3 24 | $-35.3M | $12.6M | ||
| Q2 24 | $-7.2M | $1.5M | ||
| Q1 24 | $53.8M | $15.6M |
自由现金流
ESPR
PSIX
| Q4 25 | — | $-7.6M | ||
| Q3 25 | — | $1.7M | ||
| Q2 25 | — | $14.6M | ||
| Q1 25 | — | $5.4M | ||
| Q4 24 | — | $30.0M | ||
| Q3 24 | $-35.5M | $12.1M | ||
| Q2 24 | $-7.3M | $822.0K | ||
| Q1 24 | $53.8M | $14.8M |
自由现金流率
ESPR
PSIX
| Q4 25 | — | -4.0% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 7.6% | ||
| Q1 25 | — | 4.0% | ||
| Q4 24 | — | 20.8% | ||
| Q3 24 | -68.7% | 9.7% | ||
| Q2 24 | -9.9% | 0.7% | ||
| Q1 24 | 39.0% | 15.6% |
资本支出强度
ESPR
PSIX
| Q4 25 | 0.0% | 1.6% | ||
| Q3 25 | 0.0% | 0.8% | ||
| Q2 25 | 0.0% | 1.1% | ||
| Q1 25 | 0.0% | 2.5% | ||
| Q4 24 | 0.0% | 1.8% | ||
| Q3 24 | 0.3% | 0.3% | ||
| Q2 24 | 0.1% | 0.6% | ||
| Q1 24 | 0.1% | 0.9% |
现金转化率
ESPR
PSIX
| Q4 25 | — | -0.29× | ||
| Q3 25 | — | 0.12× | ||
| Q2 25 | — | 0.33× | ||
| Q1 25 | — | 0.46× | ||
| Q4 24 | — | 1.40× | ||
| Q3 24 | — | 0.73× | ||
| Q2 24 | — | 0.07× | ||
| Q1 24 | 0.88× | 2.20× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
PSIX
| Energy End Market | $153.4M | 80% |
| Industrial End Market | $33.3M | 17% |
| Transportation End Market | $4.6M | 2% |